当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Choudhary BK and Kar A
In the present study giving emphasis on diabetes mellitus, we have taken up some specialised Ayurvedic metallic preparations (Bhasmas) like Yasada (Zn), Vanga (Sn) and Naga (Pb) Bhasmas and also Swarna (Au), Raupya (Ag), Makardhwaja (HgS) Bhasmas used in related metabolic disorders (dyslipilidemia, stress related and certain immune system disorders including ageing related complications). Though metals are not antidiabetic as such, the role of some mineral elements in the management of impaired glucose tolerance (early sign of diabetes mellitus) was well established. Also increased oxidative stress is found to be associated with the progression of diabetes mellitus and different metabolic disorders. Some metallo-enzymes like arginase, pyruvate carboxylase, manganese-superoxide dismutase are found to be beneficial in this regard. Further, it is known that nano-materials below 100 nm scale show reduced toxicity towards mammalian host and increases toxicity towards infectious organisms. As such, next for the measurement of the particle size (in nano scale) of the above Ayurvedic preparations, Transmission Electron Microscope (TEM) was used. Surprisingly all the above experimental samples are found to be within 100 nm scale and thus eliminating the risk of toxicity when used in prescribed dose. For example: Yasada Bhasma (12.5 nm), Vanga Bhasma (12.1 nm), Naga Bhasma (12.5 nm), Swarna Bhasma (12.2 nm), Raupya Bhasma (51 nm) and Makardhwaja Bhasma (39 nm).